Clinical Trials Directory

Trials / Completed

CompletedNCT01989156

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting

A Randomized, Controlled, Open-label, 3-arm Parallel Group, Multi-center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Apparently Healthy Smokers Switching to the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol) or Observing Smoking Abstinence, Compared to Continuing to Use Menthol Conventional Cigarettes, for 5 Days in Confinement and Prolonged by 86 Days in an Ambulatory Setting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Philip Morris Products S.A. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Accepted

Summary

Evaluate if the ad libitum use of the THS 2.2 Menthol (mTHS), a candidate Modified Risk Tobacco Product, for 5 days in confinement, and after 86 days in an ambulatory setting, by apparently adult healthy smokers results in a reduction in the levels of biomarkers of exposure (BoExp) to selected harmful and potentially harmful constituents (HPHCs).

Detailed description

The main goal of the study is to evaluate if the ad libitum use of the THS 2.2 Menthol (mTHS) for 5 days in confinement, and after 86 days in an ambulatory setting, by apparently adult healthy smokers results in a reduction in the levels of biomarkers of exposure (BoExp) to selected harmful and potentially harmful constituents (HPHCs) compared to smokers continuing smoking their own preferred brand of menthol conventional cigarette (mCC) and smoking abstinence (SA). Smokers who remained abstinent from SA were used as a benchmark to provide context to the exposure reduction.

Conditions

Interventions

TypeNameDescription
OTHERTHS 2.2 Menthol (mTHS 2.2)THS 2.2 Menthol ad libitum for 5 days in confinement prolonged by 86 days in an ambulatory setting
OTHERMenthol Conventional Cigarette (mCC)Subject's own preferred brand of mCC ad libitum for 5 days in confinement prolonged by 86 days in an ambulatory setting
OTHERSmoking Abstinence (SA)SA for 5 days in confinement prolonged by 86 days in an ambulatory setting

Timeline

Start date
2013-12-01
Primary completion
2014-10-01
Completion
2015-05-01
First posted
2013-11-20
Last updated
2020-03-24
Results posted
2017-04-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01989156. Inclusion in this directory is not an endorsement.